1. Home
  2. NVNI vs MURA Comparison

NVNI vs MURA Comparison

Compare NVNI & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNI
  • MURA
  • Stock Information
  • Founded
  • NVNI 2019
  • MURA 2013
  • Country
  • NVNI Brazil
  • MURA Ireland
  • Employees
  • NVNI N/A
  • MURA N/A
  • Industry
  • NVNI
  • MURA
  • Sector
  • NVNI
  • MURA
  • Exchange
  • NVNI Nasdaq
  • MURA Nasdaq
  • Market Cap
  • NVNI 31.5M
  • MURA 30.7M
  • IPO Year
  • NVNI N/A
  • MURA N/A
  • Fundamental
  • Price
  • NVNI $0.58
  • MURA $1.78
  • Analyst Decision
  • NVNI
  • MURA Strong Buy
  • Analyst Count
  • NVNI 0
  • MURA 3
  • Target Price
  • NVNI N/A
  • MURA $12.00
  • AVG Volume (30 Days)
  • NVNI 17.2M
  • MURA 281.7K
  • Earning Date
  • NVNI 08-26-2025
  • MURA 08-04-2025
  • Dividend Yield
  • NVNI N/A
  • MURA N/A
  • EPS Growth
  • NVNI N/A
  • MURA N/A
  • EPS
  • NVNI N/A
  • MURA N/A
  • Revenue
  • NVNI $31,250,627.00
  • MURA N/A
  • Revenue This Year
  • NVNI $12.05
  • MURA N/A
  • Revenue Next Year
  • NVNI $15.02
  • MURA N/A
  • P/E Ratio
  • NVNI N/A
  • MURA N/A
  • Revenue Growth
  • NVNI 1491.58
  • MURA N/A
  • 52 Week Low
  • NVNI $0.14
  • MURA $0.95
  • 52 Week High
  • NVNI $12.19
  • MURA $4.74
  • Technical
  • Relative Strength Index (RSI)
  • NVNI 54.21
  • MURA 36.95
  • Support Level
  • NVNI $0.55
  • MURA $1.53
  • Resistance Level
  • NVNI $0.61
  • MURA $1.88
  • Average True Range (ATR)
  • NVNI 0.08
  • MURA 0.16
  • MACD
  • NVNI -0.01
  • MURA 0.00
  • Stochastic Oscillator
  • NVNI 30.82
  • MURA 33.33

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: